Cargando…

Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis

INTRODUCTION: Multi-drug-resistant tuberculosis (MDR-TB) has emerged as a challenge to global tuberculosis (TB) control and remains a major public health concern in many countries. Diabetes mellitus (DM) is an increasingly recognized comorbidity that can both accelerate TB disease and complicate its...

Descripción completa

Detalles Bibliográficos
Autores principales: Tegegne, Balewgizie Sileshi, Habtewold, Tesfa Dejenie, Mengesha, Melkamu Merid, Burgerhof, Johannes G.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237566/
https://www.ncbi.nlm.nih.gov/pubmed/28088237
http://dx.doi.org/10.1186/s13643-017-0407-9
_version_ 1782495552996376576
author Tegegne, Balewgizie Sileshi
Habtewold, Tesfa Dejenie
Mengesha, Melkamu Merid
Burgerhof, Johannes G.M.
author_facet Tegegne, Balewgizie Sileshi
Habtewold, Tesfa Dejenie
Mengesha, Melkamu Merid
Burgerhof, Johannes G.M.
author_sort Tegegne, Balewgizie Sileshi
collection PubMed
description INTRODUCTION: Multi-drug-resistant tuberculosis (MDR-TB) has emerged as a challenge to global tuberculosis (TB) control and remains a major public health concern in many countries. Diabetes mellitus (DM) is an increasingly recognized comorbidity that can both accelerate TB disease and complicate its treatment. The aim of this study is to summarize available evidence on the association of DM and MDR-TB among TB patients and to provide a pooled estimate of risks. METHODS: All studies published in English before October 2016 will be searched using comprehensive search strings through PubMed, EMBASE, Web of Science, and WHO Global Health Library databases which have reported the association of DM and MDR-TB in adults with TB (age > =15). Two authors will independently collect detailed information using structured data abstraction form. The quality of studies will be checked using Newcastle-Ottawa Scale for cohort and case-control studies and the Agency for Healthcare Research and Quality tool for cross-sectional studies. Heterogeneity between included studies will be assessed using the I(2) statistic. We will check potential publication bias by visual inspection of the funnel plot and Egger’s regression test statistic. We will use the random effects model to compute a pooled estimate. DISCUSSION: Increases in the burden of non-communicable diseases and aging populations are changing the importance of different risk factors for TB, and the profile of comorbidities and clinical challenges for people with TB. Although classic risk factors and comorbidities such as overcrowding, under-nutrition, silicosis, and HIV infection are crucial to address, chronic conditions like diabetes are important factors that impair host defenses against TB. Thus, undertaking integrated multifaceted approach is remarkably necessary for reducing the burden of DM and successful TB treatment outcome. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016045692. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0407-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5237566
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52375662017-01-18 Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis Tegegne, Balewgizie Sileshi Habtewold, Tesfa Dejenie Mengesha, Melkamu Merid Burgerhof, Johannes G.M. Syst Rev Protocol INTRODUCTION: Multi-drug-resistant tuberculosis (MDR-TB) has emerged as a challenge to global tuberculosis (TB) control and remains a major public health concern in many countries. Diabetes mellitus (DM) is an increasingly recognized comorbidity that can both accelerate TB disease and complicate its treatment. The aim of this study is to summarize available evidence on the association of DM and MDR-TB among TB patients and to provide a pooled estimate of risks. METHODS: All studies published in English before October 2016 will be searched using comprehensive search strings through PubMed, EMBASE, Web of Science, and WHO Global Health Library databases which have reported the association of DM and MDR-TB in adults with TB (age > =15). Two authors will independently collect detailed information using structured data abstraction form. The quality of studies will be checked using Newcastle-Ottawa Scale for cohort and case-control studies and the Agency for Healthcare Research and Quality tool for cross-sectional studies. Heterogeneity between included studies will be assessed using the I(2) statistic. We will check potential publication bias by visual inspection of the funnel plot and Egger’s regression test statistic. We will use the random effects model to compute a pooled estimate. DISCUSSION: Increases in the burden of non-communicable diseases and aging populations are changing the importance of different risk factors for TB, and the profile of comorbidities and clinical challenges for people with TB. Although classic risk factors and comorbidities such as overcrowding, under-nutrition, silicosis, and HIV infection are crucial to address, chronic conditions like diabetes are important factors that impair host defenses against TB. Thus, undertaking integrated multifaceted approach is remarkably necessary for reducing the burden of DM and successful TB treatment outcome. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016045692. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0407-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-14 /pmc/articles/PMC5237566/ /pubmed/28088237 http://dx.doi.org/10.1186/s13643-017-0407-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Protocol
Tegegne, Balewgizie Sileshi
Habtewold, Tesfa Dejenie
Mengesha, Melkamu Merid
Burgerhof, Johannes G.M.
Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
title Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
title_full Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
title_fullStr Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
title_full_unstemmed Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
title_short Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
title_sort association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237566/
https://www.ncbi.nlm.nih.gov/pubmed/28088237
http://dx.doi.org/10.1186/s13643-017-0407-9
work_keys_str_mv AT tegegnebalewgiziesileshi associationbetweendiabetesmellitusandmultidrugresistanttuberculosisaprotocolforasystematicreviewandmetaanalysis
AT habtewoldtesfadejenie associationbetweendiabetesmellitusandmultidrugresistanttuberculosisaprotocolforasystematicreviewandmetaanalysis
AT mengeshamelkamumerid associationbetweendiabetesmellitusandmultidrugresistanttuberculosisaprotocolforasystematicreviewandmetaanalysis
AT burgerhofjohannesgm associationbetweendiabetesmellitusandmultidrugresistanttuberculosisaprotocolforasystematicreviewandmetaanalysis